Drugs / ONO-7913
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06540261 | Sep 2021 → Dec 2027 expected | colorectal cancer | Ono Pharmaceutical Co., Ltd. | Active not recruiting | No outcome recorded |
| Phase 1 | NCT06532344 | Jul 2021 → Dec 2026 expected | malignant pancreatic neoplasm | Ono Pharmaceutical Co., Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-7913 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06532344 ↗ |